Synthesis, Quantification, Characterization, and Signaling Properties of Glutathionyl Conjugates of Enals

Methods in Enzymology

Volumn 474, Issue , 2010, Pages 297-313

  Srivastava, Sanjay ^a   Ramana, Kota V ^b   Bhatnagar, Aruni ^a   Srivastava, Satish K ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NONENAL; 2-NONENAL; ALDEHYDE; GLUTATHIONE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; CELL STRAIN; CHEMISTRY; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; RAT; SIGNAL TRANSDUCTION; SYNTHESIS;

ALDEHYDES; ANIMALS; CELLS, CULTURED; GLUTATHIONE; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; PC12 CELLS; RATS; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 79958034703     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)74018-0     Document Type: Chapter

References (31)

1. Adams, J.D. Jr., Klaidman, L.K., Acrolein-induced oxygen radical formation. Free Radic. Biol. Med. 15 (1993), 187–193.
2. Alary, J., Debrauwer, L., Fernandez, Y., Cravedi, J.P., Rao, D., Bories, G., 1,4-Dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine. Chem. Res. Toxicol. 11 (1998), 130–135.
3. Benedetti, A., Comporti, M., Esterbauer, H., Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 620 (1980), 281–296.
4. Bhatnagar, A., Environmental cardiology: Studying mechanistic links between pollution and heart disease. Circ. Res. 99 (2006), 692–705.
5. Conklin, D.J., Haberzettl, P., Lesgards, J.F., Prough, R.A., Srivastava, S., Bhatnagar, A., Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity. J. Pharmacol. Exp. Ther. 331 (2009), 456–469.
6. Dianzani, M.U., 4-Hydroxynonenal and cell signalling. Free Radic. Res. 28 (1998), 553–560.
7. Dianzani, M.U., 4-Hydroxynonenal from pathology to physiology. Mol. Aspects Med. 24 (2003), 263–272.
8. Dittberner, U., Eisenbrand, G., Zankl, H., Genotoxic effects of the alpha, beta-unsaturated aldehydes 2-trans-butenal, 2-trans-hexenal and 2-trans, 6-cis-nonadienal. Mutat. Res. 335 (1995), 259–265.
9. Eaton, P., Li, J.M., Hearse, D.J., Shattock, M.J., Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am. J. Physiol. 276 (1999), H935–H943.
10. Esterbauer, H., Schaur, R.J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991), 81–128.
11. Feron, V.J., Til, H.P., de, V.F., Woutersen, R.A., Cassee, F.R., van Bladeren, P.J., Aldehydes: Occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 259 (1991), 363–385.
12. Hill, B.G., Awe, S.O., Vladykovskaya, E., Ahmed, Y., Liu, S.Q., Bhatnagar, A., Srivastava, S., Myocardial ischaemia inhibits mitochondrial metabolism of 4-hydroxy-trans-2-nonenal. Biochem. J. 417 (2009), 513–524.
13. Horvath, J.J., Witmer, C.M., Witz, G., Nephrotoxicity of the 1:1 acrolein-glutathione adduct in the rat. Toxicol. Appl. Pharmacol. 117 (1992), 200–207.
14. Ishii, T., Itoh, K., Ruiz, E., Leake, D.S., Unoki, H., Yamamoto, M., Mann, G.E., Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: Activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94 (2004), 609–616.
15. Kuiper, H.C., Miranda, C.L., Sowell, J.D., Stevens, J.F., Mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites are in vivo markers of oxidative stress. J. Biol. Chem. 283 (2008), 17131–17138.
16. Montine, K.S., Kim, P.J., Olson, S.J., Markesbery, W.R., Montine, T.J., 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J. Neuropathol. Exp. Neurol. 56 (1997), 866–871.
17. Parola, M., Robino, G., Marra, F., Pinzani, M., Bellomo, G., Leonarduzzi, G., Chiarugi, P., Camandola, S., Poli, G., Waeg, G., Gentilini, P., Dianzani, M.U., HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102 (1998), 1942–1950.
18. Ramana, K.V., Bhatnagar, A., Srivastava, S., Yadav, U.C., Awasthi, S., Awasthi, Y.C., Srivastava, S.K., Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): Role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J. Biol. Chem. 281 (2006), 17652–17660.
19. Rittner, H.L., Hafner, V., Klimiuk, P.A., Szweda, L.I., Goronzy, J.J., Weyand, C.M., Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J. Clin. Invest. 103 (1999), 1007–1013.
20. Robino, G., Zamara, E., Novo, E., Dianzani, M.U., Parola, M., 4-Hydroxy-2, 3-alkenals as signal molecules modulating proliferative and adaptative cell responses. Biofactors 15 (2001), 103–106.
21. Ruef, J., Liu, S.Q., Bode, C., Tocchi, M., Srivastava, S., Runge, M.S., Bhatnagar, A., Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler. Thromb. Vasc. Biol. 20 (2000), 1745–1752.
22. Spite, M., Summers, L., Porter, T.F., Srivastava, S., Bhatnagar, A., Serhan, C.N., Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br. J. Pharmacol. 158 (2009), 1062–1073.
23. Srivastava, S., Chandra, A., Ansari, N.H., Srivastava, S.K., Bhatnagar, A., Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal. Biochem. J. 329 (1998), 469–475.
24. Srivastava, S., Chandra, A., Wang, L.F., Seifert, W.E. Jr., Dague, B.B., Ansari, N.H., Srivastava, S.K., Bhatnagar, A., Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J. Biol. Chem. 273 (1998), 10893–10900.
25. Srivastava, S., Watowich, S.J., Petrash, J.M., Srivastava, S.K., Bhatnagar, A., Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry 38 (1999), 42–54.
26. Srivastava, S., Conklin, D.J., Liu, S.Q., Prakash, N., Boor, P.J., Srivastava, S.K., Bhatnagar, A., Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells. Atherosclerosis 158 (2001), 339–350.
27. Srivastava, S., Chandrasekar, B., Bhatnagar, A., Prabhu, S.D., Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: Role of aldose reductase. Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H2612–H2619.
28. Srivastava, S., Vladykovskaya, E., Barski, O.A., Spite, M., Kaiserova, K., Petrash, J.M., Chung, S.S., Hunt, G., Dawn, B., Bhatnagar, A., Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice. Circ. Res. 105 (2009), 793–802.
29. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N., Niki, E., Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273 (1998), 16058–16066.
30. Warnke, M.M., Wanigasekara, E., Singhal, S.S., Singhal, J., Awasthi, S., Armstrong, D.W., The determination of glutathione-4-hydroxynonenal (GSHNE), E-4-hydroxynonenal (HNE), and E-1-hydroxynon-2-en-4-one (HNO) in mouse liver tissue by LC-ESI-MS. Anal. Bioanal. Chem. 392 (2008), 1325–1333.
31. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E.R., Mizuno, Y., Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93 (1996), 2696–2701.